DIMENSIONAL FUND ADVISORS LP - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 94 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$263,000
-74.4%
221,071
-29.9%
0.00%
Q4 2021$1,028,000
+12.0%
315,195
+53.5%
0.00%
Q3 2021$918,000
-45.4%
205,303
-33.5%
0.00%
-100.0%
Q2 2021$1,682,000
-36.0%
308,651
-12.1%
0.00%0.0%
Q1 2021$2,627,000
-52.1%
351,169
-30.5%
0.00%
-50.0%
Q4 2020$5,480,000
+10.1%
505,079
-10.3%
0.00%0.0%
Q3 2020$4,976,000
-17.2%
562,802
-0.2%
0.00%
-33.3%
Q2 2020$6,010,000
+79.8%
563,7720.0%0.00%
+50.0%
Q1 2020$3,343,000
-3.5%
563,772
+12.4%
0.00%
+100.0%
Q4 2019$3,466,000
-29.7%
501,529
+5.7%
0.00%
-50.0%
Q3 2019$4,927,000
+12.1%
474,6160.0%0.00%0.0%
Q2 2019$4,394,000
+32.3%
474,616
+30.6%
0.00%
+100.0%
Q1 2019$3,322,000
+144.3%
363,442
+48.9%
0.00%0.0%
Q4 2018$1,360,000
-24.1%
244,080
+62.3%
0.00%0.0%
Q3 2018$1,791,000150,3520.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 3,139,895$23,486,0004.50%
Samsara BioCapital, LLC 2,189,199$14,769,0002.72%
Bain Capital Life Sciences Investors, LLC 5,785,036$43,272,0002.45%
Omega Fund Management, LLC 1,562,500$11,688,0001.11%
Flagship Pioneering Inc. 2,938,494$21,980,0000.35%
EcoR1 Capital, LLC 1,000,000$7,480,0000.33%
Altium Capital Management LP 126,702$948,0000.26%
Nikko Asset Management Americas, Inc. 5,042,009$37,714,0000.18%
Artal Group S.A. 1,025,000$7,667,0000.14%
Orbimed Advisors 1,837,500$13,745,0000.13%
View complete list of SYROS PHARMACEUTICALS INC shareholders